Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Fischer Medical Ventures Management Change

Fischer Medical Ventures Limited appointed Mr. David Yeow as an Additional Independent Director for five years. The company also reconstituted its Audit Committee and scheduled its 33rd AGM.

Source

BSE filing, NSE: FISCHER. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Fischer Medical Ventures Ltd: key numbers

Share price
₹26.66
Market cap
₹1,847 Cr
Revenue (annual)
₹308.6 Cr
Net profit (annual)
₹31.02 Cr
P/E (TTM)
62.0×Sector 34.1×
Promoter holding
63.08%+0.93% QoQ
FII holding
6.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Fischer Medical Ventures Ltd

All →

Other management change announcements

All →